Jan. 6 rioter still in custody
Who owns the sky?
Shooting now a homicide
Police hunt dog stabber
Jasper rebuild at an impasse
'He's negotiating against us'
Silk Road founder pardoned
Trump defends pardons
Arrests in churches green-lit
What's next for EVs?
Stargate's $500B AI fund
Netflix is raising price again
Penalties Rockets undoing
AI to judge at X Games 
Speedskaters fear ice loss
Inauguration ratings down
'It's like meat and fruit'
Diddy documentary coming
Business Jan 21 - 4,339 views
Photo: The Canadian Press
Bausch + Lomb Corp. logo is shown in a handout. The company says it's exploring several options including a potential sale of the company.
Bausch + Lomb Corp. says it's exploring several options including a potential sale of the company.
The company made the comment after a request by the Canadian Investment Regulatory Organization.
It says the company's board authorized management and its advisers to explore a potential sale, which is one of several options being examined to complete a full separation from Bausch Health Companies Inc.
It added that the process is ongoing and there is no assurance that it would result in a transaction.
Bausch + Lomb has a portfolio of about 400 products including contact lenses, lens care products, eye care products and other products.
The company was spun off from Bausch Health Companies, which continues to hold an 88 per cent stake.
